triazolam has been researched along with Amaurosis in 2 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van Reeth, O | 2 |
| Zhang, Y | 1 |
| Reddy, A | 1 |
| Zee, P | 1 |
| Turek, FW | 2 |
2 other studies available for triazolam and Amaurosis
| Article | Year |
|---|---|
Aging alters the entraining effects of an activity-inducing stimulus on the circadian clock.
Topics: Aging; Animals; Arousal; Blindness; Circadian Rhythm; Cricetinae; Eye Enucleation; Mesocricetus; Mot | 1993 |
Administering triazolam on a circadian basis entrains the activity rhythm of hamsters.
Topics: Animals; Blindness; Circadian Rhythm; Cricetinae; Male; Mesocricetus; Motor Activity; Triazolam | 1989 |